This edition includes:
- Introducing Dr. Hope Baker
- From Fatty Liver to Cancer: Understanding MASLD’s Role in HCC Development
- Semaglutide Now Approved for MASH: What Primary Care Needs to Know
- Drug-Induced Liver Injury: Updates in 2025
- Pearls & Pitfalls: Noninvasive Testing for Steatosis and MASLD
- Managing MASH Through Outreach Clinics
Author Info
